150 related articles for article (PubMed ID: 17083108)
1. MRI to assess arrhythmia and cardiomyopathies.
Macedo R; Schmidt A; Rochitte CE; Lima JA; Bluemke DA
J Magn Reson Imaging; 2006 Dec; 24(6):1197-206. PubMed ID: 17083108
[TBL] [Abstract][Full Text] [Related]
2. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.
Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
[TBL] [Abstract][Full Text] [Related]
4. Delayed enhancement MR imaging: utility in myocardial assessment.
Vogel-Claussen J; Rochitte CE; Wu KC; Kamel IR; Foo TK; Lima JA; Bluemke DA
Radiographics; 2006; 26(3):795-810. PubMed ID: 16702455
[TBL] [Abstract][Full Text] [Related]
5. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the liver: how I do it.
Semelka RC; Martin DR; Balci NC
J Gastroenterol Hepatol; 2006 Apr; 21(4):632-7. PubMed ID: 16677146
[TBL] [Abstract][Full Text] [Related]
7. [MR-based methods of the functional imaging of the central nervous system].
Giesel FL; Wüstenberg T; Bongers A; Weber MA; Zechmann C; Baudendistel KT; von Tengg-Kobligk H; Hahn HK; Essig M; Kauczor HU
Rofo; 2005 May; 177(5):714-30. PubMed ID: 15871087
[TBL] [Abstract][Full Text] [Related]
8. MRI to assess arrhythmia and cardiomyopathies: relationship to echocardiography.
Macedo R; Schmidt A; Rochitte CE; Lima JA; Bluemke DA
Echocardiography; 2007 Feb; 24(2):194-206. PubMed ID: 17313555
[TBL] [Abstract][Full Text] [Related]
9. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease.
Moraes GL; Higgins CB; Ordovas KG
J Thorac Imaging; 2013 Mar; 28(2):84-92; quiz 93-5. PubMed ID: 23422782
[TBL] [Abstract][Full Text] [Related]
10. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
Mahrholdt H; Wagner A; Judd RM; Sechtem U; Kim RJ
Eur Heart J; 2005 Aug; 26(15):1461-74. PubMed ID: 15831557
[TBL] [Abstract][Full Text] [Related]
11. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement.
Jackson E; Bellenger N; Seddon M; Harden S; Peebles C
Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263
[TBL] [Abstract][Full Text] [Related]
12. Advances in magnetic resonance (2008).
Runge VM
Invest Radiol; 2008 Dec; 43(12):893-8. PubMed ID: 19002061
[TBL] [Abstract][Full Text] [Related]
13. New MR insights of cardiomyopathy.
Rodríguez E; Soler R
Eur J Radiol; 2008 Sep; 67(3):392-400. PubMed ID: 18455342
[TBL] [Abstract][Full Text] [Related]
14. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
[TBL] [Abstract][Full Text] [Related]
15. The role of cardiovascular MRI in heart failure and the cardiomyopathies.
White JA; Patel MR
Cardiol Clin; 2007 Feb; 25(1):71-95, vi. PubMed ID: 17478241
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
[TBL] [Abstract][Full Text] [Related]
17. Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
Paldino MJ; Barboriak DP
Magn Reson Imaging Clin N Am; 2009 May; 17(2):277-89. PubMed ID: 19406359
[TBL] [Abstract][Full Text] [Related]
18. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
[TBL] [Abstract][Full Text] [Related]
19. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.
Cummings KW; Bhalla S; Javidan-Nejad C; Bierhals AJ; Gutierrez FR; Woodard PK
Radiographics; 2009; 29(1):89-103. PubMed ID: 19168838
[TBL] [Abstract][Full Text] [Related]
20. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study.
Amano Y; Matsumura Y; Kumita S
J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
